Medication info
Irbetan Tablets (Irbesartan)

Irbetan Tablets (Irbesartan)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›150mg / 1 tablet
Manufacturer / importer
BC World Pharmaceutical Co., Ltd.
Appearance
White or almost white, oval-shaped film-coated tablet with convex sides
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200800336 · Notified 2008.01.08 · Insurance code 653102080

Summary

Main use
Treatment of essential hypertension and diabetic nephropathy with hypertension in patients with type 2 diabetes
Who takes it
Adults
Adult dose
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain circumstances (such as at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be given concomitantly. The effect is enhanced particularly when coadministered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Kidney disease in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be given concomitantly to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although dosage adjustment is generally not specifically required in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
BC World Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and diabetic nephropathy with hypertension in patients with type 2 diabetes

  • Essential hypertension
  • hypertension
  • kidney disease in type 2 diabetes patients
View approved original text

This medication is used to control blood pressure in patients with essential hypertension, particularly to prevent and manage the progression of kidney disease in patients with hypertension and type 2 diabetes.

How to take

Adult dose

This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain circumstances (such as at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be given concomitantly. The effect is enhanced particularly when coadministered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Kidney disease in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be given concomitantly to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although dosage adjustment is generally not specifically required in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Precautions

This drug can cause serious harm to the fetus during pregnancy, so it should not be taken by pregnant women or women who may become pregnant. Patients with allergic reactions to this medication, severe liver impairment, or with a history of hereditary angioedema should also not use it. Caution is required for patients with moderate to severe renal impairment or those who are taking certain antihypertensive medications. Elderly patients or those with compromised liver function, as well as patients with heart or vascular diseases should use this medication cautiously and monitor for excessive drops in blood pressure. While this medication lowers blood pressure, it may cause side effects such as dizziness, headache, fatigue, and dyspepsia, so patients should carefully observe for symptoms during treatment. Because there is a risk of increased potassium levels in the blood, patients with heart or kidney diseases should have regular blood tests. This medication may interact with other antihypertensive drugs, diuretics, potassium supplements, etc., so it is important to inform healthcare professionals of any other medications being taken. Caution is necessary when driving or operating machinery as dizziness or fatigue may occur. If a pregnant woman discovers she is taking this medication, she should immediately stop taking it and consult with healthcare professionals, and it is advisable to avoid use while breastfeeding. In cases of overdose, hypotension or cardiac arrhythmias may occur, so it is essential to adhere to the prescribed dosage and report any unusual symptoms to healthcare professionals immediately. This medication should be kept out of reach of children and should not be transferred to other containers for safety.

Side effects

  • Respiratory infections
  • headache
  • musculoskeletal pain
  • dizziness
  • fatigue
  • diarrhea
  • cough
  • nausea
  • vomiting
  • musculoskeletal trauma
Show 119 more
  • chest pain
  • dyspepsia
  • heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety
  • irritability
  • upper urinary tract infection
  • fever
  • chills
  • facial swelling
  • arm swelling
  • flushing
  • heart murmurs
  • myocardial infarction
  • angina
  • arrhythmia
  • conduction abnormalities
  • cardiac-respiratory arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • hives
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastroenteritis
  • abdominal distension
  • limb edema
  • muscle spasm
  • arthritis
  • myalgia
  • joint stiffness
  • bursitis
  • muscle weakness
  • sleep disorders
  • paralysis
  • drowsiness
  • mood disorders
  • depression
  • sensory abnormalities
  • tremors
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate abnormalities
  • epistaxis
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual impairment
  • auditory abnormalities
  • earache
  • otalgia
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • increased plasma creatine kinase
  • hyperkalemia
  • weakness
  • diarrhea
  • dyspepsia
  • nausea
  • tinnitus
  • myalgia
  • increased plasma creatine kinase
  • arthralgia
  • tachycardia
  • hepatitis
  • abnormal liver function
  • renal failure
  • psoriasis
  • photosensitive reaction
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • angioedema
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • rhabdomyolysis
  • hypoglycemia
  • rhabdomyolysis
  • palpitations
  • constipation
  • dyspnea
  • sensory loss
  • hypertriglyceridemia
  • insomnia
  • taste disorder
  • thirst
  • abdominal distension
  • oral bleeding
  • increased sputum
  • decreased HDL
  • increased salivation
  • smooth surface
  • itching
  • granulocytopenia
  • leukopenia
  • erectile dysfunction
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture and is best kept in a cool, dry place below 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White or almost white, oval-shaped film-coated tablet with convex sides

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.